You've chosen Americas as your location.

To clear your location selection and return to IPS Global, click below.

Return to IPS Global

You've chosen Americas as your location.

Thank you for choosing a location. This will help us show you the information that matters the most to you.

Continue Change Selection

IPS will be exhibiting at the BPD (Biomanufacturing & Process Development) Cell and Gene Therapy Virtual Symposium & Vendor Show taking place on April 22.  

Cell and gene therapies at dozens of companies in the U.S. are being developed at an impressive rate. The combined cell (CAR-T, mesenchymal stem cells, etc.) and gene therapy (viral [AAV, Lenti] and non-viral) sectors are expected to generate an additional 200 IND submissions (with 800 current) as early as 2020, according to a FDA estimate. However, these companies face ongoing challenges including adequate product characterization, new safety risks, and the pivotal need for reliable, plus cost-effective manufacturing solutions. Currently, far less standardized equipment and methods or integrated automation is in use for cell and gene therapy product manufacturing, as compared with large molecule biopharmaceuticals. 

Learn more about this event and register on the North Carolina Biotechnology Center website.

Choose Your Location

To customize your experience, select an IPS region or country to view specific information based on your location.

  • Americas
  • United States
  • Canada
  • Brazil
  • All Other Countries

You’ve chosen as your location.

Thank you for choosing a location. This will help us show the information that means to most to you. Continue to the homepage to view featured projects, and happenings specific to your location.


We use cookies to personalize and enhance your experience on our site. Visit our Privacy Policy to learn more.